ketoconazole has been researched along with Tinea Pedis in 30 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Tinea Pedis: Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.
| Excerpt | Relevance | Reference |
|---|---|---|
| " pichinchensis with ketoconazole in patients with the clinical and mycological diagnosis of tinea pedis, we carried out a double-blind pilot study." | 9.12 | Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole. ( Herrera-Arellano, A; Navarro, V; Rojas, G; Romero-Cerecero, O; Tortoriello, J; Zamilpa-Alvarez, A, 2006) |
| "The effects of two topical cream formulations containing clotrimazole 1% and ketoconazole 2%, respectively, were clinically compared in a double-blind, randomized manner for a 28-day therapy of interdigital tinea pedis in 106 treated patients." | 9.10 | Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. ( Fladung, B; Merk, HF; Suschka, S, 2002) |
| "Thirty-five dermatologists enrolled 256 patients to assess the safety and efficacy of ketoconazole 2 percent cream, applied once daily, in the treatment of tinea pedis, tinea cruris, and tinea corporis." | 9.08 | Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis. ( Lester, M, 1995) |
| "Sixty-two patients with mycologically confirmed tinea pedis received two different treatment regimens of ketoconazole 2% cream on a randomized double-blind basis for 1 month with weekly evaluations." | 9.06 | Comparative trial of a two-dosage schedule of ketoconazole 2% cream for the treatment of tinea pedis. ( Greer, D; Jolly, HW, 1987) |
| "Twenty-nine patients with mycologically proven tinea pedis were randomly allocated to oral treatment with either ketoconazole 200 mg daily or griseofulvin 1 g daily for a period of up to 8 weeks." | 9.06 | Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis. ( Babu, KK; Cox, NH; Gentles, JC; Roberts, DT, 1987) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 7.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| "Baboon syndrome is a drug- or contact allergen-related maculopapular eruption that typically involves the flexural and gluteal areas." | 5.40 | Baboon syndrome induced by ketoconazole. ( Aliagaoglu, C; Başkan, E; Gulec, AI; Uslu, E; Yavuzcan, G, 2014) |
| " pichinchensis with ketoconazole in patients with the clinical and mycological diagnosis of tinea pedis, we carried out a double-blind pilot study." | 5.12 | Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole. ( Herrera-Arellano, A; Navarro, V; Rojas, G; Romero-Cerecero, O; Tortoriello, J; Zamilpa-Alvarez, A, 2006) |
| " In the present study, the efficacy of Oleozon in the treatment of tinea pedis was demonstrated in a controlled randomized phase III assay, comparing topical Oleozon with ketoconazole cream 2% (Nizoral) in 200 patients (100 in each group)." | 5.10 | Efficacy of ozonized sunflower oil in the treatment of tinea pedis. ( Falcón, L; Landa, N; Menéndez, S; Simón, DR, 2002) |
| "The effects of two topical cream formulations containing clotrimazole 1% and ketoconazole 2%, respectively, were clinically compared in a double-blind, randomized manner for a 28-day therapy of interdigital tinea pedis in 106 treated patients." | 5.10 | Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis. ( Fladung, B; Merk, HF; Suschka, S, 2002) |
| "Thirty-five dermatologists enrolled 256 patients to assess the safety and efficacy of ketoconazole 2 percent cream, applied once daily, in the treatment of tinea pedis, tinea cruris, and tinea corporis." | 5.08 | Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis. ( Lester, M, 1995) |
| "Sixty-two patients with mycologically confirmed tinea pedis received two different treatment regimens of ketoconazole 2% cream on a randomized double-blind basis for 1 month with weekly evaluations." | 5.06 | Comparative trial of a two-dosage schedule of ketoconazole 2% cream for the treatment of tinea pedis. ( Greer, D; Jolly, HW, 1987) |
| "Twenty-nine patients with mycologically proven tinea pedis were randomly allocated to oral treatment with either ketoconazole 200 mg daily or griseofulvin 1 g daily for a period of up to 8 weeks." | 5.06 | Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis. ( Babu, KK; Cox, NH; Gentles, JC; Roberts, DT, 1987) |
| "Sixty patients were treated for tinea pedis with 2% topical ketoconazole cream either once or twice daily." | 5.06 | Topical treatment for moccasin-type tinea pedis. ( Greer, DL, 1987) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 3.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| "Interdigital tinea pedis is the most frequent presentation, as well as the most severe clinical form of tinea pedis, constituting a therapeutic challenge." | 2.77 | Therapeutic effectiveness of Ageratina pichinchensis on the treatment of chronic interdigital tinea pedis: a randomized, double-blind clinical trial. ( Jiménez-Ferrer, E; Romero-Cerecero, O; Tortoriello, J; Zamilpa, A, 2012) |
| "rubrum." | 2.40 | Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature. ( Lucky, AW; Ploysangam, T, 1997) |
| "Baboon syndrome is a drug- or contact allergen-related maculopapular eruption that typically involves the flexural and gluteal areas." | 1.40 | Baboon syndrome induced by ketoconazole. ( Aliagaoglu, C; Başkan, E; Gulec, AI; Uslu, E; Yavuzcan, G, 2014) |
| "Ketoconazole is a useful alternative to griseofulvin when oral therapy is required and the causative organism is insensitive to griseofulvin, or infection fails to respond to griseofulvin, or griseofulvin is contraindicated due to allergy, photosensitivity, porphyrinuria, intolerance, etc." | 1.27 | Consensus of the role and positioning of the imidazoles in the treatment of dermatophytosis. ( Jones, HE, 1986) |
| "Ketoconazole is an alternative when a replacement for griseofulvin is required, provided the degree of disability justifies the risk of drug toxicity." | 1.27 | Long-term ketoconazole treatment of chronic acral dermatophyte infections. ( Hersle, K; Mobacken, H; Moberg, S, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (40.00) | 18.7374 |
| 1990's | 5 (16.67) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 6 (20.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Salehi, Z | 1 |
| Fatahi, N | 1 |
| Taran, M | 1 |
| Izadi, A | 1 |
| Badali, H | 1 |
| Hashemi, SJ | 1 |
| Rezaie, S | 1 |
| Daie Ghazvini, R | 1 |
| Ghaffari, M | 1 |
| Aala, F | 1 |
| Barac, A | 1 |
| Khodavaisy, S | 1 |
| Gobbato, AAM | 1 |
| Gobbato, CARS | 1 |
| Moreno, RA | 1 |
| Antunes, NJ | 1 |
| De Nucci, G | 1 |
| Lu, J | 1 |
| Guo, M | 1 |
| Ligui, H | 1 |
| Wu, K | 1 |
| Xiang, Y | 1 |
| Huang, J | 1 |
| Gao, L | 1 |
| Gulec, AI | 1 |
| Uslu, E | 1 |
| Başkan, E | 1 |
| Yavuzcan, G | 1 |
| Aliagaoglu, C | 1 |
| Eichenfield, LF | 1 |
| Friedlander, SF | 1 |
| Van Rooij, P | 1 |
| Declercq, J | 1 |
| Beguin, H | 1 |
| Romero-Cerecero, O | 2 |
| Zamilpa, A | 2 |
| Jiménez-Ferrer, E | 1 |
| Tortoriello, J | 3 |
| Zhang, ZY | 1 |
| Ying, ZW | 1 |
| Zhang, SY | 1 |
| Lin, JM | 1 |
| Menéndez, S | 1 |
| Falcón, L | 1 |
| Simón, DR | 1 |
| Landa, N | 1 |
| Herrera-Arellano, A | 2 |
| Rodríguez-Soberanes, A | 1 |
| de los Angeles Martínez-Rivera, M | 1 |
| Martínez-Cruz, E | 1 |
| Alvarez, L | 1 |
| Rojas, G | 1 |
| Navarro, V | 1 |
| Zamilpa-Alvarez, A | 1 |
| Méndez-Tovar, LJ | 1 |
| Manzano-Gayosso, P | 1 |
| Velásquez-Hernández, V | 1 |
| Millan-Chiu, B | 1 |
| Hernández-Hernández, F | 1 |
| Mondragón-González, R | 1 |
| López-Martínez, R | 1 |
| Meinhof, W | 1 |
| Lester, M | 1 |
| Stengel, F | 1 |
| Robles-Soto, M | 1 |
| Galimberti, R | 1 |
| Suchil, P | 1 |
| Goh, CL | 1 |
| Tay, YK | 1 |
| Ali, KB | 1 |
| Koh, MT | 1 |
| Seow, CS | 1 |
| Ploysangam, T | 1 |
| Lucky, AW | 1 |
| Tseng, SS | 1 |
| Whittier, S | 1 |
| Miller, SR | 1 |
| Zalar, GL | 1 |
| Suschka, S | 1 |
| Fladung, B | 1 |
| Merk, HF | 1 |
| Belukha, UK | 1 |
| Bidrat, MS | 1 |
| Luk'ianova, AS | 1 |
| Van Hecke, E | 1 |
| Van Cutsem, J | 1 |
| Rollman, O | 1 |
| Jameson, S | 1 |
| Lithell, H | 1 |
| Hay, RJ | 1 |
| Jones, HE | 1 |
| DeLauro, TM | 1 |
| Hodge, W | 1 |
| Stepanova, ZhV | 1 |
| Smol'iakova, LL | 1 |
| Hersle, K | 1 |
| Mobacken, H | 1 |
| Moberg, S | 1 |
| Greer, D | 1 |
| Jolly, HW | 1 |
| Roberts, DT | 1 |
| Cox, NH | 1 |
| Gentles, JC | 1 |
| Babu, KK | 1 |
| Greer, DL | 1 |
2 reviews available for ketoconazole and Tinea Pedis
| Article | Year |
|---|---|
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; I | 2017 |
Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature.
Topics: Allylamine; Antifungal Agents; Child; Child, Preschool; Ciclopirox; Coloring Agents; Female; Foot De | 1997 |
13 trials available for ketoconazole and Tinea Pedis
| Article | Year |
|---|---|
Efficacy of combination of ozonated water with oil for treatment of tinea pedis.
Topics: Allylamine; Antifungal Agents; Baths; Chi-Square Distribution; Combined Modality Therapy; Double-Bli | 2018 |
Therapeutic effectiveness of Ageratina pichinchensis on the treatment of chronic interdigital tinea pedis: a randomized, double-blind clinical trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Ageratina; Antifungal Agents; Double-Blind Method; | 2012 |
Efficacy of ozonized sunflower oil in the treatment of tinea pedis.
Topics: Adolescent; Adult; Antifungal Agents; Candida albicans; Epidermophyton; Female; Humans; Ketoconazole | 2002 |
Effectiveness and tolerability of a standardized phytodrug derived from Solanum chrysotrichum on Tinea pedis: a controlled and randomized clinical trial.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Chromatography, High Pressure Liquid; Double-Blind Metho | 2003 |
Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Ageratina; Antifungal Agents; Arthrodermataceae; | 2006 |
Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis.
Topics: Administration, Cutaneous; Adult; Female; Humans; Ketoconazole; Male; Middle Aged; Ointments; Tinea; | 1995 |
Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Topics: Adult; Candida; Candidiasis, Cutaneous; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; | 1994 |
Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis.
Topics: Adolescent; Adult; Antifungal Agents; Clotrimazole; Double-Blind Method; Drug Administration Schedul | 2002 |
Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manuum.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Griseofulvin; Hand Dermatos | 1988 |
[Experience with nizoral treatment of patients with rubromycosis].
Topics: Adolescent; Adult; Clinical Trials as Topic; Female; Hand Dermatoses; Humans; Ketoconazole; Male; Mi | 1988 |
Comparative trial of a two-dosage schedule of ketoconazole 2% cream for the treatment of tinea pedis.
Topics: Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ketocon | 1987 |
Comparison of ketoconazole and griseofulvin in the treatment of tinea pedis.
Topics: Double-Blind Method; Griseofulvin; Humans; Ketoconazole; Tinea Pedis | 1987 |
Topical treatment for moccasin-type tinea pedis.
Topics: Administration, Topical; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Humans; K | 1987 |
15 other studies available for ketoconazole and Tinea Pedis
| Article | Year |
|---|---|
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; | 2020 |
Dapaconazole versus ketoconazole in the treatment of interdigital tinea pedis.
Topics: Adult; Antifungal Agents; Female; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Ointments; Ti | 2018 |
Baboon syndrome induced by ketoconazole.
Topics: Administration, Topical; Adult; Antifungal Agents; Buttocks; Drug Eruptions; Erythema; Humans; Ketoc | 2014 |
Canine dermatophytosis caused by Trichophyton rubrum: an example of man-to-dog transmission.
Topics: Adrenal Cortex Hormones; Animals; Antifungal Agents; Dog Diseases; Dogs; Humans; Ketoconazole; Male; | 2012 |
[Observations on the efficacy of Botai ointment in treating dermatosis common among armed forces receiving at-sea training].
Topics: Adult; Dermatitis, Contact; Dermatomycoses; Dexamethasone; Drug Therapy, Combination; Eczema; Female | 2002 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Funga | 2007 |
[Ketoconazole--a change in antimycotic therapy?].
Topics: Aged; Antifungal Agents; Candidiasis, Cutaneous; Chemical and Drug Induced Liver Injury; Dermatomyco | 1983 |
In vitro evaluation of griseofulvin, ketoconazole, and itraconazole against various dermatophytes in Singapore.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Drug Resistance, Microbial; Epidermophyton; Female | 1994 |
Bilateral tinea nigra plantaris and tinea nigra plantaris mimicking melanoma.
Topics: Adult; Antifungal Agents; Diagnosis, Differential; Female; Humans; Ketoconazole; Male; Melanoma; Pig | 1999 |
[A comprehensive assessment of the phagocytic activity of the blood neutrophils in patients with rubromycosis treated with griseofulvin and nizoral].
Topics: Biological Products; Blood Bactericidal Activity; Combined Modality Therapy; Foot Dermatoses; Griseo | 1989 |
Effects of long-term ketoconazole therapy on serum lipid levels.
Topics: Adipose Tissue; Adult; Aged; Cholesterol; Female; Glucose Tolerance Test; Humans; Ketoconazole; Lipa | 1985 |
Current treatment of dermatophytoses.
Topics: Administration, Oral; Administration, Topical; Griseofulvin; Humans; Imidazoles; Ketoconazole; Onych | 1986 |
Consensus of the role and positioning of the imidazoles in the treatment of dermatophytosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Griseofulvin; Humans; Imidazoles; | 1986 |
Dermatophytosis. A review of diagnosis and current therapy.
Topics: Administration, Topical; Antifungal Agents; Dermatomycoses; Foot Dermatoses; Griseofulvin; Humans; K | 1986 |
Long-term ketoconazole treatment of chronic acral dermatophyte infections.
Topics: Female; Griseofulvin; Hand Dermatoses; Humans; Ketoconazole; Male; Middle Aged; Onychomycosis; Recur | 1985 |